Diligence memo · auto-generated · as of July 2, 2026
Renovaro Inc.
Renovaro Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Renovaro Inc. operates in Other Health Care, based in LOS ANGELES.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Renovaro Inc. has raised $123M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $107M on 2024-02-13.
Most recent recorded round closed around 2024-02-13.
Valuation (modeled)modeled
Provath models Renovaro Inc. at approximately $1.2B (range $569M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Series D+ Other Health Care companies in 2022–2024 (17 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 91 months.
Last raise 2.4 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 6.5× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Other Health Care peers (5377 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: United Digestive Holdings, LLC, DispatchHealth Holdings, Inc., Zimmer Biomet Holdings, Inc., Main Street Rural, Inc., Richmond Buyer L.P..
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.